These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 18385451)

  • 21. Mind the gap: lack of association between KIR3DL1*004/HLA‐Bw4-induced natural killer cell function and protection from HIV infection.
    Parsons MS; Boulet S; Song R; Bruneau J; Shoukry NH; Routy JP; Tsoukas CM; Bernard NF
    J Infect Dis; 2010 Nov; 202 Suppl 3():S356-60. PubMed ID: 20887224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of the inhibitory KIR ligand HLA-Bw4 and HLA-C expression levels in the recognition of leukemic cells by Natural Killer cells.
    Verheyden S; Ferrone S; Mulder A; Claas FH; Schots R; De Moerloose B; Benoit Y; Demanet C
    Cancer Immunol Immunother; 2009 Jun; 58(6):855-65. PubMed ID: 18841361
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human immunodeficiency virus type 1 infection is associated with increased NK cell polyfunctionality and higher levels of KIR3DL1+ NK cells in ugandans carrying the HLA-B Bw4 motif.
    Eller MA; Koehler RN; Kijak GH; Eller LA; Guwatudde D; Marovich MA; Michael NL; de Souza MS; Wabwire-Mangen F; Robb ML; Currier JR; Sandberg JK
    J Virol; 2011 May; 85(10):4802-11. PubMed ID: 21411516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple transcripts of the killer cell immunoglobulin-like receptor family, KIR3DL1 (NKB1), are expressed by natural killer cells of a single individual.
    Vyas Y; Selvakumar A; Steffens U; Dupont B
    Tissue Antigens; 1998 Dec; 52(6):510-9. PubMed ID: 9894849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phenotypical and functional profiles of natural killer cells exhibiting matrix metalloproteinase-mediated CD16 cleavage after anti-HIV antibody-dependent activation.
    Tang CC; Isitman G; Bruneau J; Tremblay C; Bernard NF; Kent SJ; Parsons MS
    Clin Exp Immunol; 2015 Aug; 181(2):275-85. PubMed ID: 25644502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural killer cell-mediated lysis of autologous cells modified by gene therapy.
    Liberatore C; Capanni M; Albi N; Volpi I; Urbani E; Ruggeri L; Mencarelli A; Grignani F; Velardi A
    J Exp Med; 1999 Jun; 189(12):1855-62. PubMed ID: 10377181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Time to seroconversion in HIV-exposed subjects carrying protective versus non protective KIR3DS1/L1 and HLA-B genotypes.
    Tallon BJ; Bruneau J; Tsoukas CM; Routy JP; Kiani Z; Tan X; Bernard NF
    PLoS One; 2014; 9(10):e110480. PubMed ID: 25330014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. KIR3DL1 Allotype-Dependent Modulation of NK Cell Immunity against Chronic Myeloid Leukemia.
    Izumi K; Shindo T; Ngo HT; Nakayama-Hosoya K; Akahane K; Tamai M; Nguyen TTT; Kawana-Tachikawa A; Inukai T; Takaori-Kondo A
    Immunohorizons; 2021 Aug; 5(8):687-702. PubMed ID: 34433624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HLA Mismatching Favoring Host-Versus-Graft NK Cell Activity Via KIR3DL1 Is Associated With Improved Outcomes Following Lung Transplantation.
    Greenland JR; Sun H; Calabrese D; Chong T; Singer JP; Kukreja J; Hays SR; Golden JA; Caughey GH; Venstrom JM; Rajalingam R
    Am J Transplant; 2017 Aug; 17(8):2192-2199. PubMed ID: 28375571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HLA-Bw4 in association with KIR3DL1 favors natural killer cell-mediated protection against severe COVID-19.
    Wang R; Sun Y; Kuang BH; Yan X; Lei J; Lin YX; Tian J; Li Y; Xie X; Chen T; Zhang H; Zeng YX; Zhao J; Feng L
    Emerg Microbes Infect; 2023 Dec; 12(1):2185467. PubMed ID: 36849422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. KIR3DS1-Specific D0 Domain Polymorphisms Disrupt KIR3DL1 Surface Expression and HLA Binding.
    Mulrooney TJ; Zhang AC; Goldgur Y; Boudreau JE; Hsu KC
    J Immunol; 2015 Aug; 195(3):1242-50. PubMed ID: 26109640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Analysis of KIR3DL1 expression levels on 92 cases of normal donors for hematopoietic stem cells transplant].
    Zhang J; Wang M; Bao X; Wu X; Zhou H; Zhang H; Wu D; He J
    Zhonghua Xue Ye Xue Za Zhi; 2015 Dec; 36(12):994-8. PubMed ID: 26759099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid, flow cytometric assay for NK alloreactivity reveals exceptions to rules governing alloreactivity.
    De Santis D; Foley BA; John E; Senitzer D; Christiansen FT; Witt CS
    Biol Blood Marrow Transplant; 2010 Feb; 16(2):179-91. PubMed ID: 19879950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identifying NK Alloreactive Donors for Haploidentical Hematopoietic Stem Cell Transplantation.
    Ruggeri L; Mancusi A; Urbani E; Velardi A
    Methods Mol Biol; 2016; 1393():141-5. PubMed ID: 27033224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased interferon-γ production by NK cells from KIR haplotype B carriers in hepatitis C virus infection.
    Mele D; Pasi A; Cacciatore R; Mantovani S; Oliviero B; Mondelli MU; Varchetta S
    Liver Int; 2019 Jul; 39(7):1237-1245. PubMed ID: 31177636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro education of human natural killer cells by KIR3DL1.
    Pugh J; Nemat-Gorgani N; Djaoud Z; Guethlein LA; Norman PJ; Parham P
    Life Sci Alliance; 2019 Dec; 2(6):. PubMed ID: 31723004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutational and structural analysis of KIR3DL1 reveals a lineage-defining allotypic dimorphism that impacts both HLA and peptide sensitivity.
    O'Connor GM; Vivian JP; Widjaja JM; Bridgeman JS; Gostick E; Lafont BA; Anderson SK; Price DA; Brooks AG; Rossjohn J; McVicar DW
    J Immunol; 2014 Mar; 192(6):2875-84. PubMed ID: 24563253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heterogeneous phenotypes of expression of the NKB1 natural killer cell class I receptor among individuals of different human histocompatibility leukocyte antigens types appear genetically regulated, but not linked to major histocompatibililty complex haplotype.
    Gumperz JE; Valiante NM; Parham P; Lanier LL; Tyan D
    J Exp Med; 1996 Apr; 183(4):1817-27. PubMed ID: 8666938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. General role of HLA class I molecules in the protection of target cells from lysis by natural killer cells: evidence that the free heavy chains of class I molecules are not sufficient to mediate the protective effect.
    Ciccone E; Pende D; Nanni L; Di Donato C; Viale O; Beretta A; Vitale M; Sivori S; Moretta A; Moretta L
    Int Immunol; 1995 Mar; 7(3):393-400. PubMed ID: 7794819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80.
    Cella M; Longo A; Ferrara GB; Strominger JL; Colonna M
    J Exp Med; 1994 Oct; 180(4):1235-42. PubMed ID: 7931060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.